NASDAQ · Drug Manufacturers - Specialty & Generic
SNDL (SNDL) Stock
$1.20
-1.64%
NASDAQ: SNDL
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Aurora Cannabis Generates 55% Revenue Outside Canada as Medical Sales Surge – Quarterly Update Report
Exec Edge · Jun 15, 2026
After Rough Q1, SNDL Inc (SNDL) Sees Cannabis Market Improving
Insider Monkey · May 31, 2026
SNDL's Acquisition of 1CM Ontario Locations Expected to Fail
MT Newswires · May 28, 2026
SNDL Announces Update on Arrangement Agreement with 1CM for Acquisition of Ontario Cannabis Stores
GlobeNewswire · May 27, 2026
1CM Provides Update on Arrangement Agreement with SNDL
TMX Newsfile · May 27, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held4.31%
Institutions Held22.11%
Institutions Float Held23.10%
Peer Comparison
About SNDL
SNDL is led by CEO Zachary Ryan George, employs 2,604 people, headquartered in CA, publicly traded since 2019.
SNDL stock trades at $1.20 with a market capitalization of $312.36M. The stock is valued at a price-to-earnings (P/E) ratio of -23.50, price-to-book of 0.33, price-to-sales of 0.54. Over the past 52 weeks the stock has ranged between $1.15 and $2.89, and currently trades 58.5% below its 52-week high.
On profitability, SNDL generates a return on equity (ROE) of -1.45%, return on capital employed of -0.36%, an operating margin of -0.42%, a net profit margin of -1.17%.